Principal Financial Group Inc Dexcom Inc Transaction History

Principal Financial Group Inc

$172 Billion
Q4 2024

A detailed history of Principal Financial Group Inc transactions in Dexcom Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 584,952 shares of DXCM stock, worth $50.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

584,952

Holding current value

$50.8 Million

% of portfolio

0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$65.68 - $81.01 $38.4 Million - $47.4 Million	584,952 New	584,952 $45.5 Million
Q3 2024 Oct 31, 2024	SELL	$64.0 - $116.06 $6.11 Million - $11.1 Million	-95,415 Reduced 12.32%	679,167 $45.5 Million
Q2 2024 Jul 29, 2024	SELL	$110.31 - $140.45 $2.67 Million - $3.4 Million	-24,217 Reduced 3.03%	774,582 $87.8 Million
Q1 2024 Apr 29, 2024	BUY	$114.22 - $140.1 $2.13 Million - $2.62 Million	18,678 Added 2.39%	798,799 $111 Million
Q4 2023 Feb 07, 2024	SELL	$75.49 - $124.16 $2.32 Million - $3.81 Million	-30,701 Reduced 3.79%	780,121 $96.8 Million
Q3 2023 Nov 02, 2023	BUY	$86.06 - $137.93 $66,696 - $106,895	775 Added 0.1%	810,822 $75.6 Million
Q2 2023 Aug 07, 2023	BUY	$112.47 - $130.98 $9.88 Million - $11.5 Million	87,822 Added 12.16%	810,047 $104 Million
Q1 2023 May 09, 2023	SELL	$104.0 - $122.92 $2.09 Million - $2.47 Million	-20,074 Reduced 2.7%	722,225 $83.9 Million
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $12.9 Million - $18.6 Million	151,651 Added 25.68%	742,299 $84.1 Million
Q3 2022 Nov 09, 2022	SELL	$76.35 - $94.18 $8.96 Million - $11.1 Million	-117,367 Reduced 16.58%	590,648 $47.6 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $36.6 Million - $71.4 Million	537,649 Added 315.58%	708,015 $52.8 Million
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $1.34 Million - $1.86 Million	-14,251 Reduced 7.72%	170,366 $87.2 Million
Q4 2021 Feb 09, 2022	BUY	$129.87 - $162.82 $970,908 - $1.22 Million	7,476 Added 4.22%	184,617 $99.1 Million
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $2.29 Million - $3.07 Million	21,435 Added 13.77%	177,141 $96.9 Million
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $462,938 - $616,927	5,716 Added 3.81%	155,706 $16.6 Million
Q1 2021 May 10, 2021	SELL	$84.79 - $104.74 $821,275 - $1.01 Million	-9,686 Reduced 6.07%	149,990 $53.9 Million
Q4 2020 Feb 08, 2021	SELL	$78.0 - $104.5 $466,518 - $625,014	-5,981 Reduced 3.61%	159,676 $59 Million
Q3 2020 Nov 06, 2020	SELL	$95.51 - $112.95 $460,358 - $544,419	-4,820 Reduced 2.83%	165,657 $17.1 Million
Q2 2020 Aug 05, 2020	BUY	$62.68 - $105.34 $7.85 Million - $13.2 Million	125,283 Added 277.21%	170,477 $69.1 Million
Q1 2020 May 12, 2020	BUY	$47.79 - $75.63 $749,490 - $1.19 Million	15,683 Added 53.14%	45,194 $12.2 Million
Q4 2019 Feb 05, 2020	SELL	$36.62 - $57.29 $188,556 - $294,986	-5,149 Reduced 14.86%	29,511 $6.46 Million
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $2,771 - $3,416	78 Added 0.23%	34,660 $5.17 Million
Q2 2019 Aug 12, 2019	SELL	$27.84 - $38.92 $867,216 - $1.21 Million	-31,150 Reduced 47.39%	34,582 $5.18 Million
Q1 2019 May 10, 2019	BUY	$28.07 - $38.18 $219,900 - $299,102	7,834 Added 13.53%	65,732 $7.83 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $55,518 - $76,870	-2,057 Reduced 3.43%	57,898 $6.94 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $52,350 - $82,326	2,242 Added 3.88%	59,955 $8.58 Million
Q2 2018 Aug 13, 2018	BUY	$17.54 - $25.22 $425,239 - $611,433	24,244 Added 72.44%	57,713 $0
Q1 2018 May 14, 2018	BUY	$13.06 - $18.54 $32,114 - $45,589	2,459 Added 7.93%	33,469 $2.48 Million
Q4 2017 Feb 13, 2018	SELL	$11.12 - $15.38 $21,494 - $29,729	-1,933 Reduced 5.87%	31,010 $1.78 Million
Q3 2017 Nov 02, 2017	BUY	$11.36 - $18.98 $374,232 - $625,258	32,943	32,943 $1.61 Million

Others Institutions Holding DXCM

# of Institutions

1,023

Shares Held

353M

Call Options Held

5.51M

Put Options Held

5.61M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Dexcom Inc Transaction History